skip to main content

New antithrombotic drugs: a revolution in stroke management

Bryer, Alan

Cardiovascular Journal of Africa, 2012, Vol.23(2), p.61-62 [Periódico revisado por pares]

Texto completo disponível

Ver todas as versões
Citações Citado por
  • Título:
    New antithrombotic drugs: a revolution in stroke management
  • Autor: Bryer, Alan
  • Assuntos: Editorial
  • É parte de: Cardiovascular Journal of Africa, 2012, Vol.23(2), p.61-62
  • Descrição: Embolism of cardiac origin accounts for 20% of ischaemic strokes. Atrial fibrillation is by far the most common cause of cardioembolic stroke, and anticoagulation is the treatment generally indicated for secondary, and in many cases, primary prevention.1 The decision to prescribe warfarin is usually based on an accurate assessment of the likely absolute annual risk of stroke without warfarin, and whether or not such benefits of warfarin treatment are likely to outweigh the risk of bleeding associated with its use.

Buscando em bases de dados remotas. Favor aguardar.